14 CFR 120.125
§ 120.125 Waivers from 49 CFR 40.21.
United States · 14 CFR — Aeronautics and Space · Status: effective
Cite this
- Citation
- 14 CFR 120.125, § 120.125 Waivers from 49 CFR 40.21, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/56582
- Permanent ID
ys:prov:56582@1- SHA-256
08247deb9317f066b8c1c6949c47a834010e67928794ceb795cc068c1696e911
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
An employer subject to this part may petition the Drug Abatement Division, Office of Aerospace Medicine, for a waiver allowing the employer to stand down an employee following a report of a laboratory confirmed positive drug test or refusal, pending the outcome of the verification process.
(a) Each petition for a waiver must be in writing and include substantial facts and justification to support the waiver. Each petition must satisfy the substantive requirements for obtaining a waiver, as provided in 49 CFR 40.21.
(b) Each petition for a waiver must be submitted to the Federal Aviation Administration, Office of Aerospace Medicine, Drug Abatement Division (AAM-800), 800 Independence Avenue, SW., Washington, DC 20591.
(c) The Administrator may grant a waiver subject to 49 CFR 40.21(d).
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.